Benztropine Mesylate Injection
Product Images NDC 68382-860

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benztropine Mesylate (NDC 68382-860). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

351123d8 Ffb6 49fa 8de6 63dccbaca087 01

Chemical structure of Benztropine Mesylate, showing its molecular framework including aromatic rings, methyl groups, and the mesylate component.*

FDA Label Image

351123d8 Ffb6 49fa 8de6 63dccbaca087 02

Label for Benztropine Mesylate Injection, USP, showing a strength of 2 mg/2 mL (1 mg/mL) in a 2 mL single-dose vial. The injection is for intravenous or intramuscular use. The label includes the NDC 68382-860-02 and is distributed by Zydus Pharmaceuticals USA Inc., Pennington, NJ.*

FDA Label Image

351123d8 Ffb6 49fa 8de6 63dccbaca087 03

Packaging label for Benztropine Mesylate Injection, USP 1 mg/mL strength, presented as 2 mg/2 mL (1 mg/mL) in single-dose vials. The label states the product is for intravenous or intramuscular use and is distributed by Zydus Pharmaceuticals USA Inc. The box contains 5 vials of 2 mL each. The label includes active and inactive ingredient information, dosage guidance for adults, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.